| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity, RNA polymerase II-specific | GATA2 FOXD2 SHOX POU4F1 POU4F3 OTX1 TCF7L2 HNF4A HNF4G MEIS2 HAND2 TLX1 | 1.83e-11 | 560 | 31 | 12 | GO:0001228 |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity | GATA2 FOXD2 SHOX POU4F1 POU4F3 OTX1 TCF7L2 HNF4A HNF4G MEIS2 HAND2 TLX1 | 2.07e-11 | 566 | 31 | 12 | GO:0001216 |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | GATA2 FOXD2 SHOX HSFX1 POU4F1 POU4F3 OTX1 TCF7L2 HNF4A HNF4G OLIG2 MEIS2 HAND2 TLX1 | 6.20e-09 | 1412 | 31 | 14 | GO:0000981 |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | GATA2 FOXD2 HSFX1 POU4F1 POU4F3 OTX1 TCF7L2 HNF4A HNF4G OLIG2 MEIS2 HAND2 TLX1 | 1.44e-08 | 1244 | 31 | 13 | GO:0000978 |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | GATA2 FOXD2 HSFX1 POU4F1 POU4F3 OTX1 TCF7L2 HNF4A HNF4G OLIG2 MEIS2 HAND2 TLX1 | 1.86e-08 | 1271 | 31 | 13 | GO:0000987 |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | GATA2 FOXD2 HSFX1 POU4F1 POU4F3 OTX1 TCF7L2 HNF4A HNF4G OLIG2 MEIS2 HAND2 TLX1 | 9.51e-08 | 1459 | 31 | 13 | GO:0000977 |
| GeneOntologyMolecularFunction | transcription factor binding | 1.44e-05 | 753 | 31 | 8 | GO:0008134 | |
| GeneOntologyMolecularFunction | RNA polymerase II-specific DNA-binding transcription factor binding | 3.78e-05 | 417 | 31 | 6 | GO:0061629 | |
| GeneOntologyMolecularFunction | chromatin binding | 1.12e-04 | 739 | 31 | 7 | GO:0003682 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor binding | 2.36e-04 | 582 | 31 | 6 | GO:0140297 | |
| GeneOntologyMolecularFunction | transcription coregulator binding | 1.31e-03 | 140 | 31 | 3 | GO:0001221 | |
| GeneOntologyMolecularFunction | protein domain specific binding | 2.00e-03 | 875 | 31 | 6 | GO:0019904 | |
| GeneOntologyMolecularFunction | transcription coactivator binding | 3.17e-03 | 54 | 31 | 2 | GO:0001223 | |
| GeneOntologyMolecularFunction | nuclear receptor activity | 3.90e-03 | 60 | 31 | 2 | GO:0004879 | |
| GeneOntologyMolecularFunction | ligand-activated transcription factor activity | 4.03e-03 | 61 | 31 | 2 | GO:0098531 | |
| GeneOntologyMolecularFunction | E-box binding | 4.03e-03 | 61 | 31 | 2 | GO:0070888 | |
| GeneOntologyMolecularFunction | SMAD binding | 7.86e-03 | 86 | 31 | 2 | GO:0046332 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | GATA2 CITED2 FOXD2 MED12L SHOX POU4F1 POU4F3 OTX1 TCF7L2 OGT HNF4A HNF4G OLIG2 MEIS2 HAND2 TLX1 | 1.90e-11 | 1390 | 31 | 16 | GO:0045944 |
| GeneOntologyBiologicalProcess | diencephalon development | 2.20e-07 | 90 | 31 | 5 | GO:0021536 | |
| GeneOntologyBiologicalProcess | embryonic morphogenesis | 7.64e-06 | 713 | 31 | 8 | GO:0048598 | |
| GeneOntologyBiologicalProcess | embryonic organ morphogenesis | 1.20e-05 | 351 | 31 | 6 | GO:0048562 | |
| GeneOntologyBiologicalProcess | central nervous system development | 4.56e-05 | 1197 | 31 | 9 | GO:0007417 | |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | 7.20e-05 | 1269 | 31 | 9 | GO:0009887 | |
| GeneOntologyBiologicalProcess | sensory organ development | 8.46e-05 | 730 | 31 | 7 | GO:0007423 | |
| GeneOntologyBiologicalProcess | cell fate commitment | 1.37e-04 | 338 | 31 | 5 | GO:0045165 | |
| GeneOntologyBiologicalProcess | cranial nerve development | 1.38e-04 | 67 | 31 | 3 | GO:0021545 | |
| GeneOntologyBiologicalProcess | negative regulation of DNA-templated transcription | 1.52e-04 | 1399 | 31 | 9 | GO:0045892 | |
| GeneOntologyBiologicalProcess | embryonic organ development | 1.63e-04 | 561 | 31 | 6 | GO:0048568 | |
| GeneOntologyBiologicalProcess | regulation of gluconeogenesis | 1.64e-04 | 71 | 31 | 3 | GO:0006111 | |
| GeneOntologyBiologicalProcess | negative regulation of RNA biosynthetic process | 1.64e-04 | 1413 | 31 | 9 | GO:1902679 | |
| GeneOntologyBiologicalProcess | embryo development | 1.87e-04 | 1437 | 31 | 9 | GO:0009790 | |
| GeneOntologyBiologicalProcess | animal organ formation | 2.17e-04 | 78 | 31 | 3 | GO:0048645 | |
| GeneOntologyBiologicalProcess | brain development | 2.32e-04 | 859 | 31 | 7 | GO:0007420 | |
| GeneOntologyBiologicalProcess | hindbrain development | 2.55e-04 | 208 | 31 | 4 | GO:0030902 | |
| GeneOntologyBiologicalProcess | peripheral nervous system neuron development | 2.59e-04 | 16 | 31 | 2 | GO:0048935 | |
| GeneOntologyBiologicalProcess | peripheral nervous system neuron differentiation | 2.59e-04 | 16 | 31 | 2 | GO:0048934 | |
| GeneOntologyBiologicalProcess | negative regulation of epithelial cell apoptotic process | 2.89e-04 | 86 | 31 | 3 | GO:1904036 | |
| GeneOntologyBiologicalProcess | negative regulation of developmental process | 3.40e-04 | 1220 | 31 | 8 | GO:0051093 | |
| GeneOntologyBiologicalProcess | neuron fate commitment | 3.41e-04 | 91 | 31 | 3 | GO:0048663 | |
| GeneOntologyBiologicalProcess | head development | 3.50e-04 | 919 | 31 | 7 | GO:0060322 | |
| GeneOntologyBiologicalProcess | suckling behavior | 3.68e-04 | 19 | 31 | 2 | GO:0001967 | |
| GeneOntologyBiologicalProcess | cardiac neural crest cell differentiation involved in heart development | 3.68e-04 | 19 | 31 | 2 | GO:0061307 | |
| GeneOntologyBiologicalProcess | cardiac neural crest cell development involved in heart development | 3.68e-04 | 19 | 31 | 2 | GO:0061308 | |
| GeneOntologyBiologicalProcess | regulation of gastrulation | 4.08e-04 | 20 | 31 | 2 | GO:0010470 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription regulatory region DNA binding | 4.08e-04 | 20 | 31 | 2 | GO:2000679 | |
| GeneOntologyBiologicalProcess | peripheral nervous system development | 4.24e-04 | 98 | 31 | 3 | GO:0007422 | |
| GeneOntologyBiologicalProcess | cell migration in hindbrain | 5.42e-04 | 23 | 31 | 2 | GO:0021535 | |
| GeneOntologyBiologicalProcess | nerve development | 5.79e-04 | 109 | 31 | 3 | GO:0021675 | |
| GeneOntologyBiologicalProcess | gluconeogenesis | 6.11e-04 | 111 | 31 | 3 | GO:0006094 | |
| GeneOntologyBiologicalProcess | regulation of neurotransmitter receptor localization to postsynaptic specialization membrane | 6.42e-04 | 25 | 31 | 2 | GO:0098696 | |
| GeneOntologyBiologicalProcess | hexose biosynthetic process | 6.77e-04 | 115 | 31 | 3 | GO:0019319 | |
| GeneOntologyBiologicalProcess | forebrain development | 7.49e-04 | 489 | 31 | 5 | GO:0030900 | |
| GeneOntologyBiologicalProcess | positive regulation of lipid biosynthetic process | 7.85e-04 | 121 | 31 | 3 | GO:0046889 | |
| GeneOntologyBiologicalProcess | monosaccharide biosynthetic process | 7.85e-04 | 121 | 31 | 3 | GO:0046364 | |
| GeneOntologyBiologicalProcess | negative regulation of transcription by RNA polymerase II | 7.92e-04 | 1053 | 31 | 7 | GO:0000122 | |
| GeneOntologyBiologicalProcess | catechol-containing compound biosynthetic process | 8.65e-04 | 29 | 31 | 2 | GO:0009713 | |
| GeneOntologyBiologicalProcess | catecholamine biosynthetic process | 8.65e-04 | 29 | 31 | 2 | GO:0042423 | |
| GeneOntologyBiologicalProcess | inner ear morphogenesis | 9.45e-04 | 129 | 31 | 3 | GO:0042472 | |
| GeneOntologyBiologicalProcess | mesenchymal cell differentiation | 9.63e-04 | 296 | 31 | 4 | GO:0048762 | |
| GeneOntologyBiologicalProcess | regulation of carbohydrate biosynthetic process | 1.01e-03 | 132 | 31 | 3 | GO:0043255 | |
| GeneOntologyBiologicalProcess | hematopoietic or lymphoid organ development | 1.03e-03 | 133 | 31 | 3 | GO:0048534 | |
| GeneOntologyBiologicalProcess | pattern specification process | 1.04e-03 | 526 | 31 | 5 | GO:0007389 | |
| GeneOntologyBiologicalProcess | positive regulation of gluconeogenesis | 1.05e-03 | 32 | 31 | 2 | GO:0045722 | |
| GeneOntologyBiologicalProcess | regulation of glucose metabolic process | 1.05e-03 | 134 | 31 | 3 | GO:0010906 | |
| GeneOntologyBiologicalProcess | positive regulation of cellular response to transforming growth factor beta stimulus | 1.26e-03 | 35 | 31 | 2 | GO:1903846 | |
| GeneOntologyBiologicalProcess | positive regulation of transforming growth factor beta receptor signaling pathway | 1.26e-03 | 35 | 31 | 2 | GO:0030511 | |
| GeneOntologyBiologicalProcess | regulation of protein localization to synapse | 1.49e-03 | 38 | 31 | 2 | GO:1902473 | |
| GeneOntologyBiologicalProcess | regulation of epithelial cell apoptotic process | 1.52e-03 | 152 | 31 | 3 | GO:1904035 | |
| GeneOntologyBiologicalProcess | regulation of receptor localization to synapse | 1.56e-03 | 39 | 31 | 2 | GO:1902683 | |
| GeneOntologyBiologicalProcess | ear morphogenesis | 1.57e-03 | 154 | 31 | 3 | GO:0042471 | |
| GeneOntologyBiologicalProcess | sensory organ morphogenesis | 1.66e-03 | 343 | 31 | 4 | GO:0090596 | |
| GeneOntologyBiologicalProcess | negative regulation of cell differentiation | 1.70e-03 | 875 | 31 | 6 | GO:0045596 | |
| GeneOntologyBiologicalProcess | regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 1.73e-03 | 347 | 31 | 4 | GO:0090092 | |
| GeneOntologyBiologicalProcess | response to growth factor | 1.78e-03 | 883 | 31 | 6 | GO:0070848 | |
| GeneOntologyBiologicalProcess | endocrine system development | 1.79e-03 | 161 | 31 | 3 | GO:0035270 | |
| GeneOntologyBiologicalProcess | cardiac chamber morphogenesis | 1.79e-03 | 161 | 31 | 3 | GO:0003206 | |
| GeneOntologyBiologicalProcess | cardiac ventricle development | 1.79e-03 | 161 | 31 | 3 | GO:0003231 | |
| GeneOntologyBiologicalProcess | positive regulation of lipid metabolic process | 1.92e-03 | 165 | 31 | 3 | GO:0045834 | |
| GeneOntologyBiologicalProcess | regulation of fat cell differentiation | 2.02e-03 | 168 | 31 | 3 | GO:0045598 | |
| GeneOntologyBiologicalProcess | pituitary gland development | 2.08e-03 | 45 | 31 | 2 | GO:0021983 | |
| GeneOntologyBiologicalProcess | positive regulation of binding | 2.09e-03 | 170 | 31 | 3 | GO:0051099 | |
| GeneOntologyBiologicalProcess | regulation of transcription regulatory region DNA binding | 2.17e-03 | 46 | 31 | 2 | GO:2000677 | |
| GeneOntologyBiologicalProcess | regulation of nervous system development | 2.22e-03 | 625 | 31 | 5 | GO:0051960 | |
| GeneOntologyBiologicalProcess | mesenchyme development | 2.23e-03 | 372 | 31 | 4 | GO:0060485 | |
| GeneOntologyBiologicalProcess | biogenic amine biosynthetic process | 2.27e-03 | 47 | 31 | 2 | GO:0042401 | |
| GeneOntologyBiologicalProcess | regulation of protein localization to nucleus | 2.30e-03 | 176 | 31 | 3 | GO:1900180 | |
| GeneOntologyBiologicalProcess | amine biosynthetic process | 2.36e-03 | 48 | 31 | 2 | GO:0009309 | |
| GeneOntologyBiologicalProcess | neurotransmitter receptor localization to postsynaptic specialization membrane | 2.46e-03 | 49 | 31 | 2 | GO:0099645 | |
| GeneOntologyBiologicalProcess | protein localization to postsynaptic specialization membrane | 2.46e-03 | 49 | 31 | 2 | GO:0099633 | |
| GeneOntologyCellularComponent | chromatin | CITED2 FOXD2 SHOX HSFX1 POU4F1 POU4F3 OTX1 TCF7L2 OGT HNF4A HNF4G OLIG2 MEIS2 HAND2 TLX1 | 5.35e-10 | 1480 | 31 | 15 | GO:0000785 |
| GeneOntologyCellularComponent | transcription regulator complex | 2.14e-05 | 596 | 31 | 7 | GO:0005667 | |
| GeneOntologyCellularComponent | cell cortex region | 2.03e-03 | 45 | 31 | 2 | GO:0099738 | |
| MousePheno | perinatal lethality, complete penetrance | 3.13e-06 | 712 | 26 | 9 | MP:0011089 | |
| MousePheno | perinatal lethality | GATA2 CITED2 FNDC3B ZSWIM8 POU4F1 OTX1 TCF7L2 RERE OLIG2 HAND2 | 1.83e-05 | 1130 | 26 | 10 | MP:0002081 |
| MousePheno | neonatal lethality, complete penetrance | 3.98e-05 | 534 | 26 | 7 | MP:0011087 | |
| MousePheno | abnormal sensory ganglion morphology | 4.74e-05 | 221 | 26 | 5 | MP:0000960 | |
| MousePheno | lethality during fetal growth through weaning, complete penetrance | CITED2 FNDC3B ZSWIM8 POU4F1 OTX1 TCF7L2 RERE OLIG2 MEIS2 HAND2 | 5.02e-05 | 1269 | 26 | 10 | MP:0011111 |
| MousePheno | abnormal right subclavian artery morphology | 5.39e-05 | 40 | 26 | 3 | MP:0010487 | |
| MousePheno | abnormal heart septum morphology | 6.32e-05 | 388 | 26 | 6 | MP:0006113 | |
| MousePheno | abnormal cardiac outflow tract development | 1.02e-04 | 134 | 26 | 4 | MP:0006126 | |
| MousePheno | abnormal subclavian artery morphology | 1.48e-04 | 56 | 26 | 3 | MP:0003395 | |
| MousePheno | abnormal cranial ganglia morphology | 2.86e-04 | 175 | 26 | 4 | MP:0001081 | |
| MousePheno | abnormal interventricular septum morphology | 3.67e-04 | 342 | 26 | 5 | MP:0000281 | |
| MousePheno | abnormal iris morphology | 4.07e-04 | 192 | 26 | 4 | MP:0001322 | |
| MousePheno | small cochlear ganglion | 4.45e-04 | 17 | 26 | 2 | MP:0003986 | |
| MousePheno | abnormal anterior uvea morphology | 4.66e-04 | 199 | 26 | 4 | MP:0005194 | |
| MousePheno | neonatal lethality | 4.90e-04 | 799 | 26 | 7 | MP:0002058 | |
| MousePheno | abnormal truncus arteriosus septation | 4.93e-04 | 84 | 26 | 3 | MP:0010454 | |
| MousePheno | abnormal heart and great artery attachment | 5.21e-04 | 205 | 26 | 4 | MP:0010426 | |
| MousePheno | abnormal heart and great vessel attachment | 5.51e-04 | 208 | 26 | 4 | MP:0010425 | |
| MousePheno | abnormal ureter morphology | 6.03e-04 | 90 | 26 | 3 | MP:0000534 | |
| MousePheno | small trigeminal ganglion | 6.19e-04 | 20 | 26 | 2 | MP:0001093 | |
| MousePheno | small dorsal root ganglion | 8.95e-04 | 24 | 26 | 2 | MP:0000964 | |
| MousePheno | abnormal vestibular ganglion morphology | 8.95e-04 | 24 | 26 | 2 | MP:0002856 | |
| MousePheno | abnormal dorsal root ganglion morphology | 9.18e-04 | 104 | 26 | 3 | MP:0000961 | |
| MousePheno | abnormal uvea morphology | 9.56e-04 | 241 | 26 | 4 | MP:0005197 | |
| MousePheno | decreased brain weight | 9.71e-04 | 106 | 26 | 3 | MP:0002175 | |
| Domain | Homeodomain-like | 7.54e-07 | 332 | 30 | 7 | IPR009057 | |
| Domain | Homeobox | 1.67e-06 | 234 | 30 | 6 | PF00046 | |
| Domain | HOMEOBOX_1 | 1.76e-06 | 236 | 30 | 6 | PS00027 | |
| Domain | HOX | 1.80e-06 | 237 | 30 | 6 | SM00389 | |
| Domain | Homeobox_dom | 1.89e-06 | 239 | 30 | 6 | IPR001356 | |
| Domain | HOMEOBOX_2 | 1.89e-06 | 239 | 30 | 6 | PS50071 | |
| Domain | - | 2.01e-06 | 57 | 30 | 4 | 3.30.50.10 | |
| Domain | Znf_NHR/GATA | 2.16e-06 | 58 | 30 | 4 | IPR013088 | |
| Domain | - | 5.02e-06 | 283 | 30 | 6 | 1.10.10.60 | |
| Domain | Homeobox_CS | 1.08e-05 | 186 | 30 | 5 | IPR017970 | |
| Domain | COUP_TF | 2.49e-05 | 5 | 30 | 2 | IPR003068 | |
| Domain | Retinoid-X_rcpt/HNF4 | 1.11e-04 | 10 | 30 | 2 | IPR000003 | |
| Domain | ZnF_GATA | 1.63e-04 | 12 | 30 | 2 | SM00401 | |
| Domain | Znf_GATA | 2.59e-04 | 15 | 30 | 2 | IPR000679 | |
| Domain | GATA | 2.59e-04 | 15 | 30 | 2 | PF00320 | |
| Domain | POU | 2.95e-04 | 16 | 30 | 2 | SM00352 | |
| Domain | GATA_ZN_FINGER_1 | 2.95e-04 | 16 | 30 | 2 | PS00344 | |
| Domain | POU_2 | 2.95e-04 | 16 | 30 | 2 | PS00465 | |
| Domain | Pou | 2.95e-04 | 16 | 30 | 2 | PF00157 | |
| Domain | POU_dom | 2.95e-04 | 16 | 30 | 2 | IPR000327 | |
| Domain | GATA_ZN_FINGER_2 | 2.95e-04 | 16 | 30 | 2 | PS50114 | |
| Domain | POU_3 | 2.95e-04 | 16 | 30 | 2 | PS51179 | |
| Domain | POU_1 | 2.95e-04 | 16 | 30 | 2 | PS00035 | |
| Domain | POU | 3.34e-04 | 17 | 30 | 2 | IPR013847 | |
| Domain | - | 8.54e-04 | 27 | 30 | 2 | 1.10.260.40 | |
| Domain | Lambda_DNA-bd_dom | 9.86e-04 | 29 | 30 | 2 | IPR010982 | |
| Domain | zf-C4 | 2.47e-03 | 46 | 30 | 2 | PF00105 | |
| Domain | NUCLEAR_REC_DBD_1 | 2.47e-03 | 46 | 30 | 2 | PS00031 | |
| Domain | Znf_hrmn_rcpt | 2.47e-03 | 46 | 30 | 2 | IPR001628 | |
| Domain | Nuclear_hrmn_rcpt | 2.47e-03 | 46 | 30 | 2 | IPR001723 | |
| Domain | ZnF_C4 | 2.47e-03 | 46 | 30 | 2 | SM00399 | |
| Domain | NUCLEAR_REC_DBD_2 | 2.47e-03 | 46 | 30 | 2 | PS51030 | |
| Domain | - | 2.58e-03 | 47 | 30 | 2 | 1.10.565.10 | |
| Domain | HOLI | 2.69e-03 | 48 | 30 | 2 | SM00430 | |
| Domain | Nucl_hrmn_rcpt_lig-bd | 2.69e-03 | 48 | 30 | 2 | IPR000536 | |
| Domain | Hormone_recep | 2.69e-03 | 48 | 30 | 2 | PF00104 | |
| Domain | - | 1.32e-02 | 109 | 30 | 2 | 4.10.280.10 | |
| Domain | HLH | 1.37e-02 | 111 | 30 | 2 | PF00010 | |
| Pathway | REACTOME_GENE_EXPRESSION_TRANSCRIPTION | 2.73e-05 | 1022 | 19 | 8 | MM15436 | |
| Pathway | REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION | 3.12e-05 | 1387 | 19 | 9 | M734 | |
| Pathway | PID_HIF1_TFPATHWAY | 9.00e-05 | 66 | 19 | 3 | M255 | |
| Pathway | REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_BETA_CELLS | 3.56e-04 | 21 | 19 | 2 | M14966 | |
| Pathway | REACTOME_GENERIC_TRANSCRIPTION_PATHWAY | 3.77e-04 | 768 | 19 | 6 | MM14851 | |
| Pathway | KEGG_MATURITY_ONSET_DIABETES_OF_THE_YOUNG | 5.07e-04 | 25 | 19 | 2 | M18312 | |
| Pubmed | A census of human transcription factors: function, expression and evolution. | GATA2 FOXD2 SHOX POU4F1 POU4F3 OTX1 TCF7L2 RERE HNF4A HNF4G OLIG2 MEIS2 HAND2 TLX1 | 3.20e-14 | 908 | 33 | 14 | 19274049 |
| Pubmed | GATA2 CITED2 FOXD2 POU4F3 OTX1 TCF7L2 HNF4A HNF4G MEIS2 HAND2 RNF111 | 3.01e-11 | 709 | 33 | 11 | 22988430 | |
| Pubmed | Impact of cytosine methylation on DNA binding specificities of human transcription factors. | 5.41e-11 | 544 | 33 | 10 | 28473536 | |
| Pubmed | 5.42e-11 | 28 | 33 | 5 | 38344749 | ||
| Pubmed | 1.16e-07 | 47 | 33 | 4 | 28219675 | ||
| Pubmed | 1.65e-07 | 263 | 33 | 6 | 20932939 | ||
| Pubmed | Ascl1 expression defines a subpopulation of lineage-restricted progenitors in the mammalian retina. | 1.70e-07 | 12 | 33 | 3 | 21771810 | |
| Pubmed | Loss of Axin2 Causes Ocular Defects During Mouse Eye Development. | 3.51e-07 | 15 | 33 | 3 | 27701636 | |
| Pubmed | Integral bHLH factor regulation of cell cycle exit and RGC differentiation. | 3.51e-07 | 15 | 33 | 3 | 29770538 | |
| Pubmed | The Midbrain Preisthmus: A Poorly Known Effect of the Isthmic Organizer. | 7.78e-07 | 75 | 33 | 4 | 37298722 | |
| Pubmed | 8.73e-07 | 2 | 33 | 2 | 33503426 | ||
| Pubmed | 8.73e-07 | 2 | 33 | 2 | 34973414 | ||
| Pubmed | 8.73e-07 | 2 | 33 | 2 | 21047794 | ||
| Pubmed | 8.73e-07 | 2 | 33 | 2 | 24463962 | ||
| Pubmed | Hepatocyte nuclear factor 4 is a transcription factor that constitutively binds fatty acids. | 8.73e-07 | 2 | 33 | 2 | 12220494 | |
| Pubmed | 8.73e-07 | 2 | 33 | 2 | 8622695 | ||
| Pubmed | POU4F3 Is Necessary for Normal Merkel Cell Formation, whereas POU4F1 Is Dispensable. | 8.73e-07 | 2 | 33 | 2 | 39009281 | |
| Pubmed | Induction of Hepatic Metabolic Functions by a Novel Variant of Hepatocyte Nuclear Factor 4γ. | 8.73e-07 | 2 | 33 | 2 | 30224520 | |
| Pubmed | 8.73e-07 | 2 | 33 | 2 | 25829452 | ||
| Pubmed | 8.73e-07 | 2 | 33 | 2 | 8248179 | ||
| Pubmed | 1.18e-06 | 22 | 33 | 3 | 21775418 | ||
| Pubmed | 1.55e-06 | 24 | 33 | 3 | 24335253 | ||
| Pubmed | Gata2 is a tissue-specific post-mitotic selector gene for midbrain GABAergic neurons. | 1.76e-06 | 25 | 33 | 3 | 19088086 | |
| Pubmed | A reinforcing HNF4-SMAD4 feed-forward module stabilizes enterocyte identity. | 2.62e-06 | 3 | 33 | 2 | 30988513 | |
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 34001900 | ||
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 9598366 | ||
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 19805521 | ||
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 21935940 | ||
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 8290353 | ||
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 7623109 | ||
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 31286854 | ||
| Pubmed | NONO enhances mRNA processing of super-enhancer-associated GATA2 and HAND2 genes in neuroblastoma. | 2.62e-06 | 3 | 33 | 2 | 36416237 | |
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 7935408 | ||
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 21757588 | ||
| Pubmed | Chromosomal localization and sequences of the murine Brn-3 family of developmental control genes. | 2.62e-06 | 3 | 33 | 2 | 8162704 | |
| Pubmed | 4.16e-06 | 33 | 33 | 3 | 25179941 | ||
| Pubmed | 5.23e-06 | 4 | 33 | 2 | 12544512 | ||
| Pubmed | Essential role of POU-domain factor Brn-3c in auditory and vestibular hair cell development. | 5.23e-06 | 4 | 33 | 2 | 9256502 | |
| Pubmed | 5.23e-06 | 4 | 33 | 2 | 33135183 | ||
| Pubmed | 5.23e-06 | 4 | 33 | 2 | 20361036 | ||
| Pubmed | 5.23e-06 | 4 | 33 | 2 | 22951069 | ||
| Pubmed | 5.23e-06 | 4 | 33 | 2 | 20826176 | ||
| Pubmed | Genetic interactions between Brn3 transcription factors in retinal ganglion cell type specification. | 5.23e-06 | 4 | 33 | 2 | 24116103 | |
| Pubmed | 5.23e-06 | 4 | 33 | 2 | 16357834 | ||
| Pubmed | Transcriptional Networks Controlled by NKX2-1 in the Development of Forebrain GABAergic Neurons. | 7.51e-06 | 40 | 33 | 3 | 27657450 | |
| Pubmed | 8.72e-06 | 5 | 33 | 2 | 36924494 | ||
| Pubmed | Role of transcription factors Brn-3.1 and Brn-3.2 in auditory and visual system development. | 8.72e-06 | 5 | 33 | 2 | 8637595 | |
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | 1.29e-05 | 1203 | 33 | 8 | 29180619 | |
| Pubmed | The Wilms' tumor gene Wt1 is required for normal development of the retina. | 1.31e-05 | 6 | 33 | 2 | 11889045 | |
| Pubmed | 1.31e-05 | 6 | 33 | 2 | 19559479 | ||
| Pubmed | Gfi1-Cre knock-in mouse line: A tool for inner ear hair cell-specific gene deletion. | 1.31e-05 | 6 | 33 | 2 | 20533399 | |
| Pubmed | 1.31e-05 | 6 | 33 | 2 | 27259519 | ||
| Pubmed | Requirement for Brn-3b in early differentiation of postmitotic retinal ganglion cell precursors. | 1.31e-05 | 6 | 33 | 2 | 9630743 | |
| Pubmed | 1.31e-05 | 6 | 33 | 2 | 26955760 | ||
| Pubmed | POU domain factor Brn-3b is required for the development of a large set of retinal ganglion cells. | 1.31e-05 | 6 | 33 | 2 | 8632990 | |
| Pubmed | Hnf4 activates mimetic-cell enhancers to recapitulate gut and liver development within the thymus. | 1.31e-05 | 6 | 33 | 2 | 37399024 | |
| Pubmed | 1.31e-05 | 6 | 33 | 2 | 22262898 | ||
| Pubmed | 1.31e-05 | 6 | 33 | 2 | 17601994 | ||
| Pubmed | 1.31e-05 | 6 | 33 | 2 | 11807038 | ||
| Pubmed | An atlas of combinatorial transcriptional regulation in mouse and man. | 1.53e-05 | 877 | 33 | 7 | 20211142 | |
| Pubmed | 1.77e-05 | 53 | 33 | 3 | 27210758 | ||
| Pubmed | Cited2, a coactivator of HNF4alpha, is essential for liver development. | 1.83e-05 | 7 | 33 | 2 | 17932483 | |
| Pubmed | 1.83e-05 | 7 | 33 | 2 | 9735355 | ||
| Pubmed | Class I histone deacetylases in retinal progenitors and differentiating ganglion cells. | 1.83e-05 | 7 | 33 | 2 | 30179675 | |
| Pubmed | Sumoylation is involved in beta-catenin-dependent activation of Tcf-4. | 1.83e-05 | 7 | 33 | 2 | 12727872 | |
| Pubmed | 1.83e-05 | 7 | 33 | 2 | 22554936 | ||
| Pubmed | 1.83e-05 | 7 | 33 | 2 | 22543161 | ||
| Pubmed | 1.83e-05 | 7 | 33 | 2 | 17366625 | ||
| Pubmed | 2.20e-05 | 57 | 33 | 3 | 21122108 | ||
| Pubmed | 2.44e-05 | 8 | 33 | 2 | 15069081 | ||
| Pubmed | A Tcf4-positive mesodermal population provides a prepattern for vertebrate limb muscle patterning. | 2.44e-05 | 8 | 33 | 2 | 14667415 | |
| Pubmed | 3.13e-05 | 9 | 33 | 2 | 19075394 | ||
| Pubmed | Otx1 and Otx2 activities are required for the normal development of the mouse inner ear. | 3.13e-05 | 9 | 33 | 2 | 10225993 | |
| Pubmed | Gut microbial fatty acid isomerization modulates intraepithelial T cells. | 3.13e-05 | 9 | 33 | 2 | 37380774 | |
| Pubmed | 3.13e-05 | 9 | 33 | 2 | 32537491 | ||
| Pubmed | Zfp462 deficiency causes anxiety-like behaviors with excessive self-grooming in mice. | 3.13e-05 | 9 | 33 | 2 | 27621227 | |
| Pubmed | Genetic chimeras reveal the autonomy requirements for Vsx2 in embryonic retinal progenitor cells. | 3.13e-05 | 9 | 33 | 2 | 25927996 | |
| Pubmed | 3.13e-05 | 9 | 33 | 2 | 16950124 | ||
| Pubmed | 3.18e-05 | 191 | 33 | 4 | 24146773 | ||
| Pubmed | 3.91e-05 | 10 | 33 | 2 | 16815098 | ||
| Pubmed | 3.91e-05 | 10 | 33 | 2 | 15872002 | ||
| Pubmed | 3.91e-05 | 10 | 33 | 2 | 18498634 | ||
| Pubmed | 3.91e-05 | 10 | 33 | 2 | 23805044 | ||
| Pubmed | Dysregulation of the Wnt pathway inhibits timely myelination and remyelination in the mammalian CNS. | 3.91e-05 | 10 | 33 | 2 | 19515974 | |
| Pubmed | Essential role of Gata transcription factors in sympathetic neuron development. | 4.78e-05 | 11 | 33 | 2 | 15329349 | |
| Pubmed | 4.78e-05 | 11 | 33 | 2 | 15576406 | ||
| Pubmed | Structural requirement of TAG-1 for retinal ganglion cell axons and myelin in the mouse optic nerve. | 4.78e-05 | 11 | 33 | 2 | 18650339 | |
| Pubmed | 4.78e-05 | 11 | 33 | 2 | 20333701 | ||
| Pubmed | 4.78e-05 | 11 | 33 | 2 | 8876243 | ||
| Pubmed | Requirement for Brn-3.0 in differentiation and survival of sensory and motor neurons. | 4.78e-05 | 11 | 33 | 2 | 8955272 | |
| Pubmed | The Ciliary Margin Zone of the Mammalian Retina Generates Retinal Ganglion Cells. | 4.78e-05 | 11 | 33 | 2 | 28009286 | |
| Pubmed | 4.78e-05 | 11 | 33 | 2 | 19389805 | ||
| Pubmed | Generation of a Mouse Model to Study the Noonan Syndrome Gene Lztr1 in the Telencephalon. | 4.78e-05 | 11 | 33 | 2 | 34222248 | |
| Pubmed | Molecular basis of pituitary dysfunction in mouse and human. | 5.73e-05 | 12 | 33 | 2 | 11420609 | |
| Pubmed | Frizzled3 controls axonal development in distinct populations of cranial and spinal motor neurons. | 6.77e-05 | 13 | 33 | 2 | 24347548 | |
| Pubmed | T396I mutation of mouse Sufu reduces the stability and activity of Gli3 repressor. | 6.77e-05 | 13 | 33 | 2 | 25760946 | |
| Pubmed | 6.77e-05 | 13 | 33 | 2 | 36247013 | ||
| Pubmed | 6.77e-05 | 13 | 33 | 2 | 25369423 | ||
| Pubmed | Hox11 genes are required for regional patterning and integration of muscle, tendon and bone. | 7.89e-05 | 14 | 33 | 2 | 24154528 | |
| Pubmed | GABAergic and glutamatergic identities of developing midbrain Pitx2 neurons. | 7.89e-05 | 14 | 33 | 2 | 21246650 | |
| Interaction | KRTAP6-3 interactions | 2.19e-07 | 161 | 33 | 6 | int:KRTAP6-3 | |
| Interaction | KRTAP11-1 interactions | 8.48e-07 | 108 | 33 | 5 | int:KRTAP11-1 | |
| Interaction | KRTAP22-1 interactions | 1.80e-06 | 15 | 33 | 3 | int:KRTAP22-1 | |
| Interaction | POU2AF1 interactions | 2.06e-06 | 56 | 33 | 4 | int:POU2AF1 | |
| Interaction | TLE5 interactions | 6.16e-06 | 443 | 33 | 7 | int:TLE5 | |
| Interaction | KDM6A interactions | 6.24e-06 | 162 | 33 | 5 | int:KDM6A | |
| Interaction | EMX1 interactions | 8.98e-06 | 25 | 33 | 3 | int:EMX1 | |
| Interaction | HIVEP1 interactions | 1.22e-05 | 186 | 33 | 5 | int:HIVEP1 | |
| Interaction | KRTAP6-2 interactions | 1.25e-05 | 187 | 33 | 5 | int:KRTAP6-2 | |
| Interaction | ZNF608 interactions | 1.57e-05 | 93 | 33 | 4 | int:ZNF608 | |
| Interaction | KRTAP21-2 interactions | 1.74e-05 | 31 | 33 | 3 | int:KRTAP21-2 | |
| Interaction | TLE3 interactions | 2.93e-05 | 376 | 33 | 6 | int:TLE3 | |
| Interaction | KRTAP7-1 interactions | 3.25e-05 | 38 | 33 | 3 | int:KRTAP7-1 | |
| Interaction | CREBBP interactions | 4.31e-05 | 599 | 33 | 7 | int:CREBBP | |
| Interaction | KRTAP19-2 interactions | 6.18e-05 | 47 | 33 | 3 | int:KRTAP19-2 | |
| Interaction | KMT2C interactions | 6.58e-05 | 134 | 33 | 4 | int:KMT2C | |
| Interaction | PAGR1 interactions | 7.90e-05 | 51 | 33 | 3 | int:PAGR1 | |
| Interaction | KRTAP12-4 interactions | 8.86e-05 | 53 | 33 | 3 | int:KRTAP12-4 | |
| Interaction | ZNF609 interactions | 9.19e-05 | 146 | 33 | 4 | int:ZNF609 | |
| Interaction | ATXN1L interactions | 1.02e-04 | 150 | 33 | 4 | int:ATXN1L | |
| Interaction | FAM168B interactions | 1.16e-04 | 58 | 33 | 3 | int:FAM168B | |
| Interaction | KANSL2 interactions | 2.03e-04 | 70 | 33 | 3 | int:KANSL2 | |
| Interaction | SMARCD2 interactions | 2.19e-04 | 183 | 33 | 4 | int:SMARCD2 | |
| Interaction | NFIA interactions | 2.43e-04 | 188 | 33 | 4 | int:NFIA | |
| Interaction | UBN1 interactions | 2.69e-04 | 77 | 33 | 3 | int:UBN1 | |
| Interaction | CUX1 interactions | 3.02e-04 | 199 | 33 | 4 | int:CUX1 | |
| Interaction | RING1 interactions | 3.13e-04 | 201 | 33 | 4 | int:RING1 | |
| Interaction | RNF4 interactions | 3.28e-04 | 1412 | 33 | 9 | int:RNF4 | |
| Interaction | PBX1 interactions | 3.61e-04 | 85 | 33 | 3 | int:PBX1 | |
| Interaction | KANSL3 interactions | 3.73e-04 | 86 | 33 | 3 | int:KANSL3 | |
| Interaction | USP54 interactions | 3.83e-04 | 212 | 33 | 4 | int:USP54 | |
| Interaction | PRR12 interactions | 3.99e-04 | 88 | 33 | 3 | int:PRR12 | |
| Interaction | UBN2 interactions | 4.13e-04 | 89 | 33 | 3 | int:UBN2 | |
| Interaction | TLE4 interactions | 4.55e-04 | 92 | 33 | 3 | int:TLE4 | |
| Interaction | ZNF703 interactions | 4.69e-04 | 93 | 33 | 3 | int:ZNF703 | |
| Interaction | NCOA3 interactions | 4.72e-04 | 224 | 33 | 4 | int:NCOA3 | |
| Interaction | KAT8 interactions | 5.00e-04 | 95 | 33 | 3 | int:KAT8 | |
| Interaction | ZEB2 interactions | 5.00e-04 | 95 | 33 | 3 | int:ZEB2 | |
| Interaction | DPF1 interactions | 5.00e-04 | 95 | 33 | 3 | int:DPF1 | |
| Interaction | DNTTIP1 interactions | 5.00e-04 | 95 | 33 | 3 | int:DNTTIP1 | |
| Interaction | KANSL1 interactions | 5.15e-04 | 96 | 33 | 3 | int:KANSL1 | |
| Interaction | PBX2 interactions | 5.31e-04 | 97 | 33 | 3 | int:PBX2 | |
| Interaction | NHLRC4 interactions | 5.36e-04 | 21 | 33 | 2 | int:NHLRC4 | |
| Interaction | QSER1 interactions | 5.80e-04 | 100 | 33 | 3 | int:QSER1 | |
| Interaction | KRTAP6-1 interactions | 6.33e-04 | 103 | 33 | 3 | int:KRTAP6-1 | |
| Interaction | PNRC1 interactions | 6.44e-04 | 23 | 33 | 2 | int:PNRC1 | |
| Interaction | CIC interactions | 6.95e-04 | 673 | 33 | 6 | int:CIC | |
| Interaction | PSMA3 interactions | 7.17e-04 | 443 | 33 | 5 | int:PSMA3 | |
| Interaction | MIDEAS interactions | 7.26e-04 | 108 | 33 | 3 | int:MIDEAS | |
| Interaction | ANKRD10 interactions | 7.62e-04 | 25 | 33 | 2 | int:ANKRD10 | |
| Interaction | FAM199X interactions | 7.62e-04 | 25 | 33 | 2 | int:FAM199X | |
| Interaction | FOXP1 interactions | 7.79e-04 | 256 | 33 | 4 | int:FOXP1 | |
| Interaction | ARID3B interactions | 8.28e-04 | 113 | 33 | 3 | int:ARID3B | |
| Interaction | BCL7C interactions | 8.72e-04 | 115 | 33 | 3 | int:BCL7C | |
| Interaction | KRTAP19-7 interactions | 9.16e-04 | 117 | 33 | 3 | int:KRTAP19-7 | |
| Interaction | HMG20B interactions | 1.03e-03 | 122 | 33 | 3 | int:HMG20B | |
| Interaction | ARID3A interactions | 1.03e-03 | 122 | 33 | 3 | int:ARID3A | |
| Interaction | ASXL2 interactions | 1.04e-03 | 277 | 33 | 4 | int:ASXL2 | |
| Interaction | BCL7A interactions | 1.06e-03 | 123 | 33 | 3 | int:BCL7A | |
| Interaction | RBFOX2 interactions | 1.15e-03 | 284 | 33 | 4 | int:RBFOX2 | |
| Interaction | TCF7L2 interactions | 1.16e-03 | 285 | 33 | 4 | int:TCF7L2 | |
| Interaction | MCCD1 interactions | 1.17e-03 | 31 | 33 | 2 | int:MCCD1 | |
| Interaction | RBBP5 interactions | 1.19e-03 | 287 | 33 | 4 | int:RBBP5 | |
| Interaction | CXXC1 interactions | 1.30e-03 | 132 | 33 | 3 | int:CXXC1 | |
| Interaction | NOTO interactions | 1.33e-03 | 33 | 33 | 2 | int:NOTO | |
| Interaction | SINHCAF interactions | 1.38e-03 | 135 | 33 | 3 | int:SINHCAF | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 1.75e-04 | 15 | 24 | 2 | 82 | |
| GeneFamily | POU class homeoboxes and pseudogenes | 4.20e-04 | 23 | 24 | 2 | 523 | |
| GeneFamily | Nuclear hormone receptors | 1.91e-03 | 49 | 24 | 2 | 71 | |
| GeneFamily | PRD class homeoboxes and pseudogenes | 6.57e-03 | 92 | 24 | 2 | 521 | |
| GeneFamily | Basic helix-loop-helix proteins | 9.28e-03 | 110 | 24 | 2 | 420 | |
| Coexpression | BENPORATH_SUZ12_TARGETS | GATA2 FOXD2 SHOX POU4F1 PHLDB1 POU4F3 OTX1 OTOP3 GUCY1A2 OLIG2 HAND2 TLX1 | 1.47e-09 | 1035 | 32 | 12 | M9898 |
| Coexpression | BENPORATH_PRC2_TARGETS | 3.24e-09 | 650 | 32 | 10 | M8448 | |
| Coexpression | BENPORATH_ES_WITH_H3K27ME3 | GATA2 FOXD2 SHOX POU4F1 PHLDB1 POU4F3 OTX1 OTOP3 OLIG2 HAND2 TLX1 | 4.45e-08 | 1115 | 32 | 11 | M10371 |
| Coexpression | BENPORATH_EED_TARGETS | 3.18e-07 | 1059 | 32 | 10 | M7617 | |
| Coexpression | THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN | 7.76e-06 | 227 | 32 | 5 | M11234 | |
| Coexpression | NAKAJIMA_MAST_CELL | 2.42e-05 | 46 | 32 | 3 | M389 | |
| Coexpression | GSE27859_MACROPHAGE_VS_CD11C_INT_F480_INT_DC_UP | 5.45e-05 | 171 | 32 | 4 | M8594 | |
| Coexpression | MIKKELSEN_MEF_HCP_WITH_H3K27ME3 | 7.05e-05 | 591 | 32 | 6 | M2019 | |
| Coexpression | MIKKELSEN_MEF_HCP_WITH_H3K27ME3 | 7.73e-05 | 601 | 32 | 6 | MM866 | |
| Coexpression | GSE8515_CTRL_VS_IL6_4H_STIM_MAC_DN | 9.07e-05 | 195 | 32 | 4 | M5765 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_stage III -IV renal corpusc_emap-27945_top-relative-expression-ranked_1000 | 1.52e-05 | 837 | 30 | 8 | gudmap_developingKidney_e15.5_stage III -IV renal corpusc_1000 | |
| ToppCell | COVID-19-Mast_cells|COVID-19 / group, cell type (main and fine annotations) | 5.26e-06 | 156 | 33 | 4 | 159504d43421ee83b9ab484816333ae549c9c2fd | |
| ToppCell | COVID-19-Mast_cells-Mast_cells|COVID-19 / group, cell type (main and fine annotations) | 5.26e-06 | 156 | 33 | 4 | bc10b94673184ef384c6665b16a1209a8975a4f1 | |
| ToppCell | mild-Myeloid-Eosinophils|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 6.26e-06 | 163 | 33 | 4 | 7c57d541a88e9afa079e95b8a6ecdea60a0c6aaa | |
| ToppCell | nucseq-Immune-Hematopoietic-Granulocytic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.57e-06 | 165 | 33 | 4 | 37615622c736e43260c38016e7c9e565ac97a3e8 | |
| ToppCell | nucseq-Immune-Hematopoietic-Granulocytic-Mast/Basophil|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.57e-06 | 165 | 33 | 4 | 640bb71e74a61df2fcb01ceeabe4c493ef836b21 | |
| ToppCell | nucseq-Immune-Hematopoietic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.57e-06 | 165 | 33 | 4 | f3df74b5763130c71c0a482a3a23f6b22acc2892 | |
| ToppCell | severe-Myeloid-Eosinophils|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 7.39e-06 | 170 | 33 | 4 | 863f0266d5837cdbc3e09a3fe6a99dd3e6261674 | |
| ToppCell | mild-Myeloid-Eosinophils|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 7.56e-06 | 171 | 33 | 4 | 5c8198182495bda7a826e9d80aa467f4eb1094ec | |
| ToppCell | 10x3'2.3-week_14-16-Hematopoietic-HSC/MPP_and_pro-eo/baso/mast_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 7.74e-06 | 172 | 33 | 4 | 7fb43b3938b9a3b6935ec22d9d853e7d47b82b3c | |
| ToppCell | Immune-mast_cell|World / Lineage, Cell type, age group and donor | 7.74e-06 | 172 | 33 | 4 | 6e8e0aac5a20dbc789bf8c6916833bb8709a411a | |
| ToppCell | 3'_v3-bone_marrow-Mast|bone_marrow / Manually curated celltypes from each tissue | 9.26e-06 | 180 | 33 | 4 | b37ee81b792213d6595b4ec65d04bc35d83321c7 | |
| ToppCell | systemic_lupus_erythematosus-managed-Hematopoietic-progenitor_cell-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 9.46e-06 | 181 | 33 | 4 | 070ae3f3fe0e177fabcf34e64a0f158b01354837 | |
| ToppCell | critical-Myeloid-Mast_cell|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 9.46e-06 | 181 | 33 | 4 | f0d81ae74d3f32979624a94b2ef93774831a7970 | |
| ToppCell | systemic_lupus_erythematosus-managed-Hematopoietic-progenitor_cell|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.12e-05 | 189 | 33 | 4 | 6687a93ac8540ece5fd762f6f77c1f25f159195b | |
| ToppCell | droplet-Heart-nan-3m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-05 | 189 | 33 | 4 | 8e583ec4df0f5b79ce5211cc99ecd8616d180bde | |
| ToppCell | droplet-Heart-nan-3m-Endothelial-endocardial_endothelial_cells|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-05 | 189 | 33 | 4 | fb2253b8463d08b3d28e952a31a23dea2c2d986b | |
| ToppCell | droplet-Heart-4Chambers-21m-Endothelial-endocardial_endothelial_cells|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.24e-05 | 194 | 33 | 4 | c5e77650d7abee339ec38fa78a622bb124db3fa5 | |
| ToppCell | 10x5'v1-week_17-19-Myeloid_neutrophil-granulo-eo/baso/mast|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.27e-05 | 195 | 33 | 4 | f1f48e2e57b2282572959b152aad4bee05143f03 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Neuronal-midbrain/hindbrain_cells|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 1.29e-05 | 196 | 33 | 4 | 0767581b69bc7e6334d580ca02ed1e831b7b55da | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.29e-05 | 196 | 33 | 4 | 7d5eaed189aa6116f3799be010139fb675ec65e0 | |
| ToppCell | MS-IIF-Others-HSPC|IIF / Disease, condition lineage and cell class | 1.37e-05 | 199 | 33 | 4 | 3384db80f6024bcabe2625f24d5f4e0d3d8caa7e | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Neuronal-Neuron|10w / Sample Type, Dataset, Time_group, and Cell type. | 1.40e-05 | 200 | 33 | 4 | 332905a686356cd1e024d40679be98e9d8b1b5e8 | |
| ToppCell | primary_visual_cortex-Non-neuronal-oligodendrocyte-Oligo-Oligo_Rassf10|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.75e-05 | 95 | 33 | 3 | 0ac6cba7e0ed6083f777287f39a871461fa1bca4 | |
| ToppCell | lymphoid-T_cell-pro-T_cell|lymphoid / Lineage, cell class and subclass | 5.21e-05 | 98 | 33 | 3 | 4da11182885d5f2673e85bd9c5717939b0268427 | |
| ToppCell | PBMC-Mild-Myeloid-Neutrophil-Neutrophil-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 6.96e-05 | 108 | 33 | 3 | c647f6595e7cccea91429a2377c9de6cc1acff4d | |
| ToppCell | frontal_cortex-Non-neuronal-oligodendrocyte-Oligo-Oligo_Rassf10|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 9.29e-05 | 119 | 33 | 3 | ec3af1253f03b3ec403f73243237acf08ad56789 | |
| ToppCell | Fetal_29-31_weeks-Immune-mast_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.32e-04 | 134 | 33 | 3 | 1d6e74612fd91a2ef9d14bf77262b2d08e1052ca | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-hematologic-hematopoietic_progenitor-common_myeloid_progenitor|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.41e-04 | 137 | 33 | 3 | 6d90da42dcc06aa895f920218055068f3c76d57d | |
| ToppCell | primary_visual_cortex-Non-neuronal-oligodendrocyte-Oligo-OPC_Pdgfra_Grm5|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.47e-04 | 139 | 33 | 3 | a957ea4e581646c76b16b6a7f89579b8c7ac35b6 | |
| ToppCell | Fetal_29-31_weeks-Immune-mast_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.67e-04 | 145 | 33 | 3 | dc89d817a9bef24a07e992efdab4136f12ceb399 | |
| ToppCell | Children_(3_yrs)-Immune-mast_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.70e-04 | 146 | 33 | 3 | f7349d63bb47f1f22ced8ff514edc1c11bc782e7 | |
| ToppCell | 356C-Myeloid-Mast_cell|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.77e-04 | 148 | 33 | 3 | 1668d8a9e680da335362744f36b05446c499347e | |
| ToppCell | 356C-Myeloid-Mast_cell-|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.77e-04 | 148 | 33 | 3 | 18511ba10765eda937c5a710626361f7e6b9b321 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-04 | 148 | 33 | 3 | ba277c898678dd36f8dc1d681301c71901b89055 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-04 | 148 | 33 | 3 | b4632029ebd14969bda59a1bd1454eadb8efe563 | |
| ToppCell | Myeloid-Myeloid-E_(Neutrophils)|Myeloid / shred on cell class and cell subclass (v4) | 1.84e-04 | 150 | 33 | 3 | 1bffb8d86b737ac43be902d9468041aef3542f1f | |
| ToppCell | Children_(3_yrs)-Immune-mast_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.88e-04 | 151 | 33 | 3 | bbf735c6433c3fc2feedb24ed6f48c51d545fb60 | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-myeloid-myeloid_granulocytic|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.91e-04 | 152 | 33 | 3 | 32634195048858ae84605c61e43c542d90f7cab5 | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-myeloid-myeloid_granulocytic-mast_cell|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.91e-04 | 152 | 33 | 3 | 0eb185b2404f015efff1bd140e0c502d714720fb | |
| ToppCell | Adult-Immune-mast_cell-D122|Adult / Lineage, Cell type, age group and donor | 2.03e-04 | 155 | 33 | 3 | 7c9de0591d1bf756b8e268b278bbe10bd5415dcd | |
| ToppCell | Children_(3_yrs)-Immune-mast_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.11e-04 | 157 | 33 | 3 | ec185dbeabb67fd9ca85f71cab88463b60f9b1c1 | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-myeloid-myeloid_granulocytic-mast_cell|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.19e-04 | 159 | 33 | 3 | ecd1daa33549541aee3bf4e139ab6732efc8e74c | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-high_Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.19e-04 | 159 | 33 | 3 | 2607b562903228274fbd96168ba826782fab0b53 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-high_Fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.19e-04 | 159 | 33 | 3 | e812cbde59188924c6277c3feadf1a9592fa62a4 | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-myeloid-myeloid_granulocytic|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.19e-04 | 159 | 33 | 3 | 7b6370c9567da7d40541c6e243efa704ed7e90ae | |
| ToppCell | NS-critical-d_16-33-Myeloid-Mast_cell|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.23e-04 | 160 | 33 | 3 | c61869d9dbba250270e59366e15af204e5b4395d | |
| ToppCell | Adult-Immune-mast_cell|Adult / Lineage, Cell type, age group and donor | 2.27e-04 | 161 | 33 | 3 | 44f5c0256b3ce264a6c7b62740f32dcd45ee052d | |
| ToppCell | Children_(3_yrs)-Immune-dendritic_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.27e-04 | 161 | 33 | 3 | cd41abb7ae659d3d314281783a0aaad562b26037 | |
| ToppCell | Fetal_29-31_weeks-Immune-mast_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.35e-04 | 163 | 33 | 3 | 03b2ec226adffba3ce893f3d12e549c841e662fd | |
| ToppCell | IIF-Other-HSPC|IIF / Disease, Lineage and Cell Type | 2.35e-04 | 163 | 33 | 3 | 1e0d38fbed38ac48478868a1480172a1a3f7c1b7 | |
| ToppCell | 356C-Myeloid-Mast_cell|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 2.39e-04 | 164 | 33 | 3 | b3192c443f4848e6a8afdb89c155f9ec42a154b0 | |
| ToppCell | 356C-Myeloid-Mast_cell-|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 2.39e-04 | 164 | 33 | 3 | f7288ec4daf494dae770ea6c58bead27660ccae1 | |
| ToppCell | facs-Kidney-nan-24m-Mesenchymal-mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.44e-04 | 165 | 33 | 3 | c746bb22ef52d7f7fa6ee9c37ae6bbe0ccce718e | |
| ToppCell | facs-Kidney-nan-24m-Mesenchymal-mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.44e-04 | 165 | 33 | 3 | 4cdd80580d5638fd649280ba3893251c2f898f3f | |
| ToppCell | moderate-Myeloid-Mast_cell|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.48e-04 | 166 | 33 | 3 | c3835b424c63bf11a4e2c47635dc3787fc4a637a | |
| ToppCell | remission-HSPC|World / disease stage, cell group and cell class | 2.48e-04 | 166 | 33 | 3 | d269ee6f7adb55b05dcb5eaea96629ccb0b2d6e3 | |
| ToppCell | TCGA-Colorectal|World / Sample_Type by Project: Shred V9 | 2.48e-04 | 166 | 33 | 3 | c018cd8c7a82251c67e3dc812d4d21e527a43456 | |
| ToppCell | 343B-Myeloid-Mast_cell-|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 2.48e-04 | 166 | 33 | 3 | 4e47e7f3019fb2dcbc35b4e9b47ee265a97cec5c | |
| ToppCell | 10x3'2.3-week_14-16-Hematopoietic-erythroid-late_erythroid|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.48e-04 | 166 | 33 | 3 | b4e5466a33578103d197cf67f37e7ec88e09281f | |
| ToppCell | wk_20-22-Hematologic-Myeloid-Mast|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.48e-04 | 166 | 33 | 3 | 004ab6a1425d812c7ce572205875fd702d4a9659 | |
| ToppCell | Posterior_cortex-Macroglia-POLYDENDROCYTE|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 2.48e-04 | 166 | 33 | 3 | a7ac5a414e3e2ff01f1c452c0a85048b17cba0b6 | |
| ToppCell | 343B-Myeloid-Mast_cell|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 2.48e-04 | 166 | 33 | 3 | f6e2ec767c022982ef416fadb998a7b6b958f76a | |
| ToppCell | 10x5'-lymph-node_spleen-Mast-Mast_cells|lymph-node_spleen / Manually curated celltypes from each tissue | 2.57e-04 | 168 | 33 | 3 | 650ad3ea52577887885d82457dbc04202ce3eb34 | |
| ToppCell | Bronchial_Biopsy-Immune-Mast_cells|Immune / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.57e-04 | 168 | 33 | 3 | 45ccc0cb42d21f4853190e8e9ed9a54aefefe738 | |
| ToppCell | ASK428-Immune-Mast_cell|Immune / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.57e-04 | 168 | 33 | 3 | c399fcb4d1d0be48026c2ecabc34a5935e7adf73 | |
| ToppCell | 10x5'-lymph-node_spleen-Mast|lymph-node_spleen / Manually curated celltypes from each tissue | 2.57e-04 | 168 | 33 | 3 | e58ffbb57c81967766755c3f6f347b158a39cb0d | |
| ToppCell | 356C-Endothelial_cells-Endothelial-B_(Artery)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.61e-04 | 169 | 33 | 3 | 337be3bf485b54afad86e256cb0c4c1d0c2a9a2a | |
| ToppCell | Control-Mast_cells|Control / group, cell type (main and fine annotations) | 2.61e-04 | 169 | 33 | 3 | fdb9abca1d0f4fdc32dd8ac6231651ef34aa5afb | |
| ToppCell | 356C-Endothelial_cells-Endothelial-B_(Artery)|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.61e-04 | 169 | 33 | 3 | 605cc2638271803cf1d972ab3fa8f13f89666376 | |
| ToppCell | wk_15-18-Hematologic-Meg-ery-Megakaryocyte|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.61e-04 | 169 | 33 | 3 | d571e84e01e3316748d4407ed98881b17484e035 | |
| ToppCell | 10x5'v1-week_14-16-Hematopoietic-HSC/MPP_and_pro-eo/baso/mast_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.61e-04 | 169 | 33 | 3 | 60fd3d06c5f61c1f021329d18b3bc605dda4af07 | |
| ToppCell | 10x5'v1-week_12-13-Myeloid_neutrophil-granulo-eo/baso/mast-eosinophil|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.61e-04 | 169 | 33 | 3 | f68195510b91e287fe1507455ca067ece77a3897 | |
| ToppCell | Frontal_cortex-Macroglia-POLYDENDROCYTE|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 2.61e-04 | 169 | 33 | 3 | 50cc0f5a022b95986949db63208a627cef9f4a69 | |
| ToppCell | COVID-19-lung-MAST|lung / Disease (COVID-19 only), tissue and cell type | 2.66e-04 | 170 | 33 | 3 | e90f18e5462381b38e918442b38b1c8105291908 | |
| ToppCell | Control-Myeloid-Mast|Control / Disease state, Lineage and Cell class | 2.66e-04 | 170 | 33 | 3 | 9a14deb7f7cd4a49c217eba4023f7bf1dec6c902 | |
| ToppCell | COVID-19_Convalescent-Hematopoietic_SC|COVID-19_Convalescent / Disease group, lineage and cell class | 2.66e-04 | 170 | 33 | 3 | 8a73d5334eed1cd9fdcc3ebeae0bdf9f945c228a | |
| ToppCell | Control-Mast_cells-Mast_cells|Control / group, cell type (main and fine annotations) | 2.66e-04 | 170 | 33 | 3 | c80f6d29096c372da95a8407f402349ff1bb7018 | |
| ToppCell | 3'_v3-bone_marrow-Mast-Mast_cell_lympho|bone_marrow / Manually curated celltypes from each tissue | 2.66e-04 | 170 | 33 | 3 | 4dedf482cd4521b3f87d2b5ae80f7a3ea8686a15 | |
| ToppCell | PBMC-Convalescent-Hematopoietic-HSPC|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.71e-04 | 171 | 33 | 3 | 172db31a37b72fb87fe5f0f79da51866b90dd1ad | |
| ToppCell | wk_20-22-Hematologic-Myeloid-Eosinophil|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.71e-04 | 171 | 33 | 3 | fa6e856e62b82ec4972e0098e73f237cc611891f | |
| ToppCell | PBMC-Convalescent-Hematopoietic-HSPC-HSPC|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.71e-04 | 171 | 33 | 3 | 2031797d579ce373921affad70da6e50eec13664 | |
| ToppCell | control-Myeloid-Eosinophils|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 2.71e-04 | 171 | 33 | 3 | 82f736c33ed96c0865618e8f8eb82a5487126bdc | |
| ToppCell | Control-Myeloid-Mast|World / Disease state, Lineage and Cell class | 2.71e-04 | 171 | 33 | 3 | ed8e61d524f4cddc6084b261175df54d2a64a60f | |
| ToppCell | remission-HSPC|remission / disease stage, cell group and cell class | 2.71e-04 | 171 | 33 | 3 | 41b424e58470a2fc25632aea50a37c7c5ea17645 | |
| ToppCell | PBMC-Convalescent-Hematopoietic-HSPC-HSPC-|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.71e-04 | 171 | 33 | 3 | a4e13b304ef414722ffdc06560deeab41785e956 | |
| ToppCell | Myeloid-Myeloid-D_(Mast_cell)|Myeloid / shred on cell class and cell subclass (v4) | 2.71e-04 | 171 | 33 | 3 | 5f1aafc4c55a9c6c3153430186a8a351425a3cb9 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.6.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.75e-04 | 172 | 33 | 3 | c8ea80042faf923b08ff03d73100533d521d73ef | |
| ToppCell | PBMC-Convalescent-Hematopoietic-HSPC-HSPC-|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.75e-04 | 172 | 33 | 3 | 8fd3db757d54949bd583d5f0eadf63a32342cb9d | |
| ToppCell | 10x3'2.3-week_17-19-Myeloid_neutrophil-granulo-eo/baso/mast-eosinophil|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.75e-04 | 172 | 33 | 3 | 3a76cfb2832790144a6da6406469ead0767916b5 | |
| ToppCell | ILEUM-inflamed-(4)_Mast|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.75e-04 | 172 | 33 | 3 | be82f749f4b1049ae8832facc052082cf5463c11 | |
| ToppCell | 3'_v3-blood-Mast|blood / Manually curated celltypes from each tissue | 2.75e-04 | 172 | 33 | 3 | e7a46bbeff749ca59b9f1357409ce1ad59dd22dd | |
| ToppCell | PBMC-Convalescent-Hematopoietic-HSPC-HSPC|Convalescent / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.75e-04 | 172 | 33 | 3 | 382cb5fea099110eb026a8bba6cf4c28763ea52f | |
| ToppCell | ILEUM-inflamed-(4)_Mast_cells|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.75e-04 | 172 | 33 | 3 | 7185b28282412f3a464b2a8ad5605475a1a31358 | |
| ToppCell | PBMC-Convalescent-Hematopoietic-HSPC|Convalescent / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.75e-04 | 172 | 33 | 3 | da78f7a71b7f05c5c484c9ed19ba37c55d35e870 | |
| ToppCell | 10x3'2.3-week_12-13-Myeloid_neutrophil-granulo-eo/baso/mast-eosinophil|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.80e-04 | 173 | 33 | 3 | 1e4afa020fae682521335b440ccd33c16f37156f | |
| ToppCell | 368C-Myeloid-Mast_cell|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 2.80e-04 | 173 | 33 | 3 | 8cffb4a37d30b6626188309b868ac4a62e91262f | |
| ToppCell | 368C-Myeloid-Mast_cell-|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 2.80e-04 | 173 | 33 | 3 | fb87ea74bf70aa83b458edf728c81857c8b8eb96 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Epithelial-epithelial_progenitor_cell-Distal_progenitor|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.80e-04 | 173 | 33 | 3 | 81c36b9fe02c59099f080b2db02f4eaf2783911f | |
| ToppCell | 10x3'2.3-week_17-19-Hematopoietic-HSC/MPP_and_pro-eo/baso/mast_precursor|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.85e-04 | 174 | 33 | 3 | 64d13a7a9757e85f4f4af876c687dd18a7efa01a | |
| ToppCell | 10x5'-GI_small-bowel-Mast|GI_small-bowel / Manually curated celltypes from each tissue | 2.85e-04 | 174 | 33 | 3 | e94c980b25edfd0e8598c416828801fcc00e8ead | |
| Drug | indomethacin, USP; Up 200; 20uM; MCF7; HG-U133A | 8.13e-06 | 193 | 33 | 5 | 262_UP | |
| Drug | Tetracycline hydrochloride [64-75-5]; Down 200; 8.4uM; MCF7; HT_HG-U133A | 9.43e-06 | 199 | 33 | 5 | 2243_DN | |
| Disease | maturity-onset diabetes of the young type 1 (implicated_via_orthology) | 9.99e-07 | 2 | 30 | 2 | DOID:0111099 (implicated_via_orthology) | |
| Disease | Fanconi syndrome (implicated_via_orthology) | 5.99e-06 | 4 | 30 | 2 | DOID:1062 (implicated_via_orthology) | |
| Disease | maturity-onset diabetes of the young (implicated_via_orthology) | 4.47e-05 | 10 | 30 | 2 | DOID:0050524 (implicated_via_orthology) | |
| Disease | Tetralogy of Fallot | 1.19e-04 | 16 | 30 | 2 | C0039685 | |
| Disease | corneal hysteresis | 1.88e-04 | 20 | 30 | 2 | EFO_0010066 | |
| Disease | Left Ventricle Remodeling | 2.07e-04 | 21 | 30 | 2 | C0600520 | |
| Disease | Ventricular Remodeling | 2.07e-04 | 21 | 30 | 2 | C0600519 | |
| Disease | sex interaction measurement, body mass index, age at assessment | 2.49e-04 | 23 | 30 | 2 | EFO_0004340, EFO_0008007, EFO_0008343 | |
| Disease | TYPE 2 DIABETES MELLITUS | 3.72e-04 | 28 | 30 | 2 | 125853 | |
| Disease | Type 2 diabetes mellitus | 3.72e-04 | 28 | 30 | 2 | cv:C0011860 | |
| Disease | aspartate aminotransferase measurement, serum alanine aminotransferase measurement, low density lipoprotein triglyceride measurement, body fat percentage, high density lipoprotein cholesterol measurement, sex hormone-binding globulin measurement | 4.84e-04 | 364 | 30 | 4 | EFO_0004612, EFO_0004696, EFO_0004735, EFO_0004736, EFO_0007800, EFO_0009946 | |
| Disease | brain infarction (biomarker_via_orthology) | 5.17e-04 | 33 | 30 | 2 | DOID:3454 (biomarker_via_orthology) | |
| Disease | Congenital Heart Defects | 9.21e-04 | 44 | 30 | 2 | C0018798 | |
| Disease | obesity (implicated_via_orthology) | 1.34e-03 | 215 | 30 | 3 | DOID:9970 (implicated_via_orthology) | |
| Disease | behavior | 1.44e-03 | 55 | 30 | 2 | GO_0007610 | |
| Disease | body fat percentage | 1.44e-03 | 488 | 30 | 4 | EFO_0007800 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SHHNVFPDGKPFPHH | 151 | Q14956 | |
| HQGPPMHHVPGHESR | 351 | P33240 | |
| MLGLPEHFLHHHPSS | 126 | P19113 | |
| PHMGAHPATAPFHLH | 321 | Q7RTS5 | |
| GLLGGSAHPHPHMHS | 181 | Q01851 | |
| SAHPHPHMHSLGHLS | 186 | Q01851 | |
| PHMHSLGHLSHPAAA | 191 | Q01851 | |
| QHHLLLYHTHPMPKP | 1706 | Q86YW9 | |
| APSPSPMHSHHHRAF | 561 | Q7LDG7 | |
| HGPPMHSYLPSHPHH | 421 | O14770 | |
| ASAPPVGPHRHFHAH | 1311 | Q5JU85 | |
| DAPHAHHPLHPHLMQ | 381 | P41235 | |
| HHPLHPHLMQEHMGT | 386 | P41235 | |
| HLPTHPHLPTHPMMS | 26 | A8MZA4 | |
| NDGSHLHHPMHPHLS | 331 | Q14541 | |
| LHHPMHPHLSQDPLT | 336 | Q14541 | |
| HSHHHPHQLSPMAPS | 256 | P32242 | |
| PMAPSSMAGHHHHHP | 266 | P32242 | |
| MSLVGGFPHHPVVHH | 1 | P61296 | |
| HMAPVGHLPPFSHSG | 436 | P23769 | |
| MGTAVGPHHSPAPHD | 1 | Q9Y6Z2 | |
| EMGPPHHHPGHRMPH | 581 | Q8IWX8 | |
| AMSPTHHLPPYLTHH | 116 | Q53EP0 | |
| HPHHSMLYPLSHGFR | 506 | O15294 | |
| FMLSPCHMHHHPGHV | 16 | O15225 | |
| PHPHPHPHAFAFAAA | 286 | O60548 | |
| PEGTLMLHYFHPHHI | 231 | P33402 | |
| ASMVMFPHLPALHHH | 381 | Q9UBD0 | |
| PHLHPHLAAHAPYLM | 226 | O15266 | |
| PPPHHHVSAMGAGSL | 301 | Q13516 | |
| PLHPAANPMEHFARH | 1336 | Q9P2R6 | |
| WLHGHPHMHGGHLPS | 1536 | Q9P2R6 | |
| PAQIHPHHLGAMGHL | 141 | Q15319 | |
| HHHPAHRMGMGQFPS | 21 | Q99967 | |
| HRMGMGQFPSPHHHQ | 26 | Q99967 | |
| PNYGHGHHIHVPQTM | 781 | Q6ZNA4 | |
| SRFPPHMVPPHHTLH | 291 | Q9NQB0 | |
| SGFPPLMHHSILHHL | 1081 | Q86UU1 | |
| YLTHPAHPAHPMPHM | 1521 | A7E2V4 | |
| MEHLGPHHLHPGHAE | 1 | P31314 |